• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Microbes Infect . MERS-CoV Seroconversion amongst Malaysian Hajj Pilgrims Returning from the Middle East, 2016-2018: Results from the MERCURIA

tetano

Editor, Senior Moderator
Emerg Microbes Infect


. 2023 Apr 26;2208678.
doi: 10.1080/22221751.2023.2208678. Online ahead of print. MERS-CoV Seroconversion amongst Malaysian Hajj Pilgrims Returning from the Middle East, 2016-2018: Results from the MERCURIAL Multiyear Prospective Cohort Study

Jefree Johari[SUP] 1 [/SUP], Robert D Hontz[SUP] 2 [/SUP], Brian L Pike[SUP] 2 [/SUP], Tupur Husain[SUP] 2 [/SUP], Norhayati Rusli[SUP] 3 [/SUP], Rozainanee Mohd-Zain[SUP] 3 [/SUP], Vunjia Tiong[SUP] 1 [/SUP], Hai-Yen Lee[SUP] 1 [/SUP], Boon-Teong Teoh[SUP] 1 [/SUP], Sing-Sin Sam[SUP] 1 [/SUP], Chee-Sieng Khor[SUP] 1 [/SUP], Shih-Keng Loong[SUP] 1 [/SUP], Juraina Abd-Jamil[SUP] 1 [/SUP], Siti-Sarah Nor'e[SUP] 1 [/SUP], Hasmawati Yahaya[SUP] 1 [/SUP], Naim Che-Kamaruddin[SUP] 1 [/SUP], Jose A Garcia-Rivera[SUP] 4 [/SUP], Sazaly AbuBakar[SUP] 1 [/SUP]



Affiliations
Abstract

Prospective cohort study to investigate the potential exposure to the Middle East Respiratory Syndrome-Coronavirus (MERS-CoV) following Hajj pilgrims is still very limited. Here, we report the antibody seroconversion study results obtained from successive three years cohort studies (2016-2018) involving the Malaysian Hajj pilgrims returning from the Middle East. A cohort study of Hajj pilgrims from Malaysia enrolled 2,863 participants from 2016-2018, all of whom consented to provide paired blood samples for both pre- and post-Hajj travel to the Middle East. ELISAs and micro-neutralization assays were performed to detect the presence of MERS-CoV IgG antibodies. Sociodemographic data, symptoms experienced during Hajj, and history of exposure to camels or camel products were recorded using structured pre- and post-Hajj questionnaires. A 4-fold increase in anti-MERS-CoV IgG between paired pre-Hajj and post-Hajj serum samples in twelve participants was observed. None of the twelve ELISA-positive sera had detectable levels of virus-neutralizing antibodies. All reportedly had mild symptoms of respiratory symptoms at a certain point during the pilgrimage, implying mild or asymptomatic infections. No association between post-Hajj serum positivity and a history of exposure to camels or camel products was obtained. Findings from the study suggest that serologic conversion to MERS-CoV occurred in at least 0.6% of the Hajj pilgrims returning from the Middle East. Since all the seroconvertants had mild to no symptoms during the sampling period, it highlights the likelihood of occurrence of only low infectivity spillover infections among the Hajj pilgrims.

Keywords: Acute Respiratory Infection; Epidemiology; Hajj Pilgrims; Infectious diseases; MERS-CoV; Malaysia; Seroconversion; Serology.

 
Back
Top